Nico Vandervelpen
Directeur/Membre du Conseil chez SEPS Pharma NV
Provenance du réseau au premier degré de Nico Vandervelpen
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
Ernst & Young LLP (Missouri)
 Ernst & Young LLP (Missouri) Miscellaneous Commercial ServicesCommercial Services Ernst & Young provides accounting services. Its services include auditing, accounting, tax and transaction services, assurance and advisory business, online transaction advisory and a wide range of financial services. The company was founded by Arthur Young and Alwin C. Ernst in 1881 and is headquartered in Kansas City, MO.
186
| Subsidiary | Miscellaneous Commercial Services | 186 |
Apitope Technology (Bristol) Ltd.
 Apitope Technology (Bristol) Ltd. Miscellaneous Commercial ServicesCommercial Services Apitope Technology (Bristol) Ltd. is a European biotech company developing therapeutic vaccines for treating autoimmune and allergic diseases, including multiple sclerosis, Type 1 diabetes, Graves' disease, allergies and organ transplant rejection. The team at Apitope is developing potential therapies intended to selectively treat the underlying cause of a range of autoimmune diseases rather than simply treat the disease symptoms or non-specifically suppress the whole immune system. Apitope's approach is based on well-established scientific evidence published in leading scientific journals showing that soluble, synthetic peptides can selectively suppress abnormal immune responses and reinstate the normal immune balance and thereby, tolerance. The firm's strategy is to position itself as a significant player in the therapeutic peptide space and make it a partner of choice for pharmaceutical companies keen to develop disease modifiers for autoimmune conditions. It has a highly experienced senior management team, with a proven track record in discovering and developing innovative compounds. The company's lead product candidate is under investigation for the potential treatment of multiple sclerosis and is currently in Phase I clinical development. It is partnered with Merck-Serono (a division of Merck KGaA, Darmstadt, Germany), one of the leading companies in the development and marketing of MS therapies.
11
| Subsidiary | Miscellaneous Commercial Services | 11 |
| Public Company | Pharmaceuticals: Major | 10 | |
SEPS Pharma NV
 SEPS Pharma NV Pharmaceuticals: GenericHealth Technology SEPS Pharma NV provides controlled drug delivery and develops self emulsifying pro drug systems. Its services include preformulation, formulation development and analytical development. The company was founded on October 19, 2007 and is headquartered in Diepenbeek, Belgium.
4
| Subsidiary | Pharmaceuticals: Generic | 4 |
Fast Forward Pharmaceuticals BV
 Fast Forward Pharmaceuticals BV Medical SpecialtiesHealth Technology Fast Forward Pharmaceuticals BV develops novel disease-modifying therapeutics for the treatment of inflammatory and autoimmune diseases. It is developing an anti-CD40 monoclonal antibody therapy for the treatment of chronic inflammatory diseases like primary biliary cirrhosis and Crohn’s disease. The company was founded by Louis Boon in October 2010 and is headquartered in Utrecht, Netherlands.
1
| Holding Company | Medical Specialties | 1 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Nico Vandervelpen via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| JOHNSON & JOHNSON | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Ernst & Young LLP
 Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Chief Executive Officer Corporate Officer/Principal | |
Apitope International NV
 Apitope International NV BiotechnologyHealth Technology Apitope International NV develops therapeutic vaccines. It operates as a bio-pharmaceutical company that engages in developing peptide therapies. The firm specializes on the discovery and development of revolutionary disease modifying therapies for treating autoimmune and allergic diseases, including multiple sclerosis, and Graves’ disease, FVIII intolerance and uveitis. The company was founded by David Wraith in 2002 and is headquartered in Diepenbeek, Belgium. | Biotechnology | Director/Board Member Chairman Founder Chairman Chief Executive Officer Corporate Officer/Principal Corporate Officer/Principal Chief Operating Officer | |
| University of California, Los Angeles | College/University | Masters Business Admin Masters Business Admin Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| Université Catholique de Louvain | College/University | Graduate Degree Graduate Degree Graduate Degree | |
| New York University | College/University | Graduate Degree Graduate Degree Masters Business Admin | |
| University of Michigan | College/University | Masters Business Admin Undergraduate Degree Masters Business Admin | |
| TIGENIX NV | Medical Specialties | Director/Board Member Public Communications Contact Corporate Officer/Principal | |
ProFibrix BV
 ProFibrix BV BiotechnologyHealth Technology ProFibrix BV develops and markets products for the hemostasis and regenerative medicine markets. Its product in pipeline, ProFibrix, is a hemostatic agent for mild to moderate surgical bleeding. The firm operates through its offices located in Leiden and Seattle. It is a subsidiary of The Medicines Company. The company was founded in 2004 by Jaap Koopman and is headquartered in Leiden, the Netherlands. | Biotechnology | Chairman Director/Board Member Director/Board Member | |
CreditSights, Inc.
 CreditSights, Inc. Investment ManagersFinance CreditSights, Inc. is an independent investment research firm headquartered in New York City. The firm was co-founded by Paul Ciasullo, Reena Mithal, Glenn Reynolds and Peter Petas in 2000. They are a subsidiary of Fitch Group, Inc., ultimately owned by The Hearst Family Trust. CreditSights provides fundamental, in-depth credit research for buy-side decisionmakers, sell-side intermediaries and wealth managers and private banks globally. The firm actively covers more than 5,000 companies in North America, Europe, and Asia-Pacific representing over 56 countries. | Investment Managers | Analyst-Fixed Income Analyst-Fixed Income | |
| Wilfrid Laurier University | College/University | Undergraduate Degree Undergraduate Degree | |
Palladio Biosciences, Inc.
 Palladio Biosciences, Inc. BiotechnologyHealth Technology Palladio Biosciences, Inc. develops transformative medicines for orphan diseases. Its pipeline includes Lixivaptan, a selective vasopressin V2 receptor antagonist for the treatment of polycystic kidney disease, a life-threatening genetic disease. The company was founded by Lorenzo Pellegrini in 2015 and is headquartered in Newtown, PA. | Biotechnology | Chief Executive Officer Director/Board Member | |
| Vesalius Biocapital II Partners SARL | Corporate Officer/Principal Founder | ||
| University of Virginia | College/University | Graduate Degree Masters Business Admin | |
| The State University of New York | College/University | Undergraduate Degree Undergraduate Degree | |
Gadeta BV
 Gadeta BV Medical SpecialtiesHealth Technology Gadeta BV discovers and develops novel cancer immunotherapies. It provides groundbreaking discoveries regarding the role of cell receptors in the broad of heamatological and solid tumor cells. The firm develops t-cells engineered to express a defined gamma delta, an anti- cancer product that eradicates tumors. The company was founded by Jurgen Kuball in 2015 and is headquartered in Utrecht, Netherlands. | Medical Specialties | Director/Board Member Director/Board Member | |
TD Securities, Inc.
 TD Securities, Inc. Investment Banks/BrokersFinance TD Securities, Inc. is a Canadian broker/dealer headquartered in Toronto, Ontario. The firm is a subsidiary of The Toronto-Dominion Bank (NYSE, TSE: TD). TD Securities provides a wide range of capital market products and services to corporate, government and institutional clients. Their services also include the underwriting and distribution of new debt and equity issues, providing advice on strategic acquisitions and divestitures and executing daily trading and investment needs. The firm’s equity group provides research coverage of various sectors. Their fixed-income group provides a full range of underwriting sales and trading products for Canadian, US and European debt issuers and investors. | Investment Banks/Brokers | Analyst-Equity Analyst-Equity | |
KPMG, Inc.
 KPMG, Inc. Miscellaneous Commercial ServicesCommercial Services Part of KPMG International Cooperative, KPMG, Inc. provides audit and accounting services. The company is based in Vancouver, Canada. The CEO of the Canadian company is Walter R. Pela. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
| University of Notre Dame | College/University | Graduate Degree Graduate Degree | |
| State University of New York at Binghamton | College/University | Masters Business Admin Undergraduate Degree | |
| Texas A&M University | College/University | Graduate Degree Undergraduate Degree | |
Housatonic Management Co., Inc.
 Housatonic Management Co., Inc. Investment ManagersFinance Housatonic Management Co. Inc (Housatonic Partners) is a private equity firm founded in 1994 by William Nicholas Thorndike, Michael C Jackson and Eliot Wadsworth. The firm is headquartered in San Francisco, California. | Investment Managers | Comptroller/Controller/Auditor Corporate Officer/Principal | |
| Syracuse University | College/University | Undergraduate Degree Masters Business Admin | |
The American Institute of Certified Public Accountants
 The American Institute of Certified Public Accountants Miscellaneous Commercial ServicesCommercial Services The American Institute of Certified Public Accountants provides vocational education in accounting. The company provides services to the accounting community, regulatory bodies, and other organizations. It also operates in Jersey City, Washington, and Lewisville. It was founded in 1887 and is headquartered in New York City, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
| Healthcare Financial Management Association | Corporate Officer/Principal Director/Board Member | ||
| Baruch College | College/University | Undergraduate Degree Undergraduate Degree | |
Roark Capital Group, Inc.
 Roark Capital Group, Inc. Investment ManagersFinance Roark Capital Group, Inc. (Roark Capital) is a private equity firm founded in 2001 by Neil K. Aronson. The firm is headquartered in Atlanta, Georgia. | Investment Managers | Private Equity Investor Investment Committee Member | |
Vesalius Biocapital Partners SARL
 Vesalius Biocapital Partners SARL Investment ManagersFinance Vesalius Biocapital Partners SARL (Vesalius Biocapital Partners) is an independent venture capital firm founded in 2007 by Stéphane Verdood. The firm is headquartered in Luxembourg. | Investment Managers | Founder Private Equity Investor | |
Biotechnological Enzymatic Catalyse NV
 Biotechnological Enzymatic Catalyse NV Food: Major DiversifiedConsumer Non-Durables Biotechnological Enzymatic Catalyse NV develops, produces and commercializes enzymatic systems for food preservation. It engages in the research, development and manufacturing of antimicrobial products for food safety. The firm's solutions are designed for use in the following: dairy products, fruit and vegetable juices, sauces and dressings and liquid egg products. The company was founded in 1992 and is headquartered in Ghent, Belgium. | Food: Major Diversified | Director/Board Member Director/Board Member | |
Cellaïon SA
 Cellaïon SA BiotechnologyHealth Technology Cellaïon SA is a biotech company located in Mont Saint Guibert, Belgium. Cellaïon aims to restore a favorable environment to reboost the regenerative process of the liver and ensure a second life to the native liver instead of losing it. The Belgian company has a strong IP base issued from their own research and academic research at UCLouvain, developed with the objective to generate new products. Cellaïon's treatment covers the wide spectrum of liver diseases, from the highly life-threatening acute-on-chronic liver-failure (ACLF) and acute alcoholic hepatitis, to intermediate severity acute decompensation of cirrhosis (AD) and progressive chronic liver diseases caused by non-alcoholic steatohepatitis (NASH). The company has built up a series of R&D and collaborative partnerships with both industrial and academic partners, allowing Cellaïon to broaden and accelerate its clinical development. The company was founded by Etienne Marc Sokal, who has been the CEO since incorporation. | Biotechnology | Director/Board Member Director/Board Member | |
| Ghent University | College/University | Doctorate Degree Doctorate Degree | |
| University of Cambridge | College/University | Doctorate Degree Doctorate Degree | |
Goldman Sachs & Co. LLC
 Goldman Sachs & Co. LLC Investment Banks/BrokersFinance Goldman Sachs & Co. LLC (GS&Co.) is a securities brokerage firm headquartered in New York City. Founded in 1927, the firm is a subsidiary of The Goldman Sachs Group, Inc. (NYSE: GS). GS&Co. provides services to help hedge funds manage risk, monitor portfolios, maintain liquidity and build their businesses. They offer clients access to global equity and derivatives markets, as well as foreign exchange, commodities, European Lefts, rates and credit across the Americas, Europe and Asia. The firm proactively monitors capital markets, searching for pockets of liquidity and news that may require changes to those strategies. Integration with the Goldman Sachs network gives clients access to the firm's sectored block trades and their insights into price discovery. Their electronic trading program provides clients with tools to manage their trades from pre-trade analytics to post-trade analysis. | Investment Banks/Brokers | Analyst-Equity Analyst-Equity | |
Mind-NRG SARL
 Mind-NRG SARL Medical/Nursing ServicesHealth Services Mind-NRG SARL specializes in research and development programs with focus on the treatment psychiatric and neurologic diseases. The company was founded in 2010 and is headquartered in Geneva, Switzerland. | Medical/Nursing Services | Chairman Director/Board Member | |
| Boston College | College/University | Undergraduate Degree Undergraduate Degree | |
Ogeda SA
 Ogeda SA Pharmaceuticals: MajorHealth Technology Ogeda SA discovers and develops small molecule drugs. It develops NK3 antagonists for the treatment of hormone-dependent pathologies in the field of Women's Health. The company was founded in 1994 and is headquartered in Gosselies, Spain. | Pharmaceuticals: Major | Director/Board Member | |
Tennessee Society of Certified Public Accountants
 Tennessee Society of Certified Public Accountants Miscellaneous Commercial ServicesCommercial Services The Tennessee Society of Certified Public Accountants (TSCPA) is the state professional organization for certified public accountants. The society's membership is comprised of members in industry, government, business, education and public accounting. It acts on behalf of its members and provides support, enabling its members to perform quality professional services while serving the public interest. The company was founded in 1924 and is located in Brentwood, TN. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
LHP Hospital Group, Inc.
 LHP Hospital Group, Inc. Hospital/Nursing ManagementHealth Services LHP Hospital Group, Inc. provides essential hospital capital and expertise to not-for-profit hospitals and hospital systems, with which it forms joint ventures to own, operate, and manage acute care. The company founded by Daniel J. Moen in 2008 and is headquartered in Austin, TX. | Hospital/Nursing Management | Director/Board Member | |
Ardent Health Partners, Inc.
 Ardent Health Partners, Inc. Hospital/Nursing ManagementHealth Services Ardent Health Partners, Inc. engages in the provision of healthcare and related services. It also owns and operates hospitals, through its subsidiaries. The company was founded in 1993 and is headquartered in Nashville, TN. | Hospital/Nursing Management | Director of Finance/CFO | |
Deloitte & Touche LLP
 Deloitte & Touche LLP Miscellaneous Commercial ServicesCommercial Services Deloitte & Touche LLP engages in the provision of audit, advisory, financial advisory, tax, and consulting services. The company was founded on March 7, 1995 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Comptroller/Controller/Auditor | |
PGI Holdings, Inc. (Tennessee)
 PGI Holdings, Inc. (Tennessee) Medical/Nursing ServicesHealth Services PGI Holdings, Inc. (Tennessee) engages in the provision of anatomic, clinical, and molecular pathology services. Its services include dermatology, forensic medicine, gastroenterology, hematology oncology, hospital services, infectious disease testing, urology, molecular oncology, neuropathology, and non-gyn cytopathology. The company was founded in 1996 and is headquartered in Brentwood, TN. | Medical/Nursing Services | Comptroller/Controller/Auditor | |
| The University of North Carolina at Asheville | College/University | Graduate Degree |
Statistiques
Internationale
| Etats-Unis | 30 |
| Belgique | 8 |
| Pays-Bas | 4 |
| Canada | 4 |
| Royaume-Uni | 3 |
Sectorielle
| Consumer Services | 17 |
| Health Technology | 11 |
| Finance | 8 |
| Commercial Services | 7 |
| Health Services | 6 |
Opérationnelle
| Corporate Officer/Principal | 202 |
| Director/Board Member | 182 |
| Undergraduate Degree | 73 |
| Director of Finance/CFO | 63 |
| Chairman | 38 |
Relations les plus connectées
| Insiders | |
|---|---|
| Michèle Ollier | 40 |
| Stéphane Verdood | 32 |
| Alain Parthoens | 29 |
| James Turley | 27 |
| William John Jenkins | 20 |
| Mark de Boer | 19 |
| Stewart Bloom | 18 |
| Gabriel T. Rozman | 17 |
| Lorenzo Pellegrini | 14 |
| Eran Rotem | 12 |
| Kris Motmans | 12 |
| Tim C. Gillis | 12 |
| Jonathan Andrew Lambert | 11 |
| Luc Audet | 11 |
| Smeraldo Fiorentini | 10 |
- Bourse
- Insiders
- Nico Vandervelpen
- Connexions Sociétés
